ABSTRACT The segesterone acetate and ethinyl estradiol contraceptive vaginal ring (SA/EE CVR) was FDA-approved in August 2018 and is now available in the U.S. The CVR is placed vaginally for ..... see more
If the address matches an existing account you will receive an email with instructions to reset your password. see more
The two primary aims of the present study were to determine if college women rely on certain sources of information about contraception more than other sources, and to examine if ..... see more
Annovera (segesterone acetate and ethinyl estradiol vaginal system) is a US Food and Drug Administration FDA-approved long-lasting, reversible contraceptive that is fully administered by the user and does not require ..... see more
Uncovering Issues in Long-Term Contraception
Barriers to LARC implementation include deficits in healthcare provider (HCP) education and training. Insufficient education on the latest practice guidelines contributes to fewer correctly identified women who are eligible for LARC. Providers who lack training in the insertion and removal of these devices may not suggest LARCs as a first-line method and must refer patients to other HCPs for LARC provision. Referring candidates causes delays in care, access, and the establishment of trust towards providers. Surveys and interviews with women accentuate a lack of information regarding the accessibility of LARCs as well as concerns pertaining to the procedures required and possible side effects.
• Bahamondes, Luis, et al. "Long-acting reversible contraceptive (LARCs) methods." Best Practice & Research Clinical Obstetrics & Gynaecology (2019).
• Baron, Melyssa, Beth Potter, and Sarina Schrager. "A review of long-acting reversible contraception methods and barriers to their use." WMJ 117.4 (2018): 156-159.
• Beshar, Isabel, et al. "Socioeconomic differences persist in use of permanent vs long-acting reversible contraception: An analysis of the National Survey of Family Growth, 2006 to 2010 vs 2015 to 2017." Contraception 103.4 (2021): 246-254.
• Festin, Mario Philip R. "Overview of modern contraception." Best Practice & Research Clinical Obstetrics & Gynaecology (2020).
• Phillips, Jessamyn, and Prabjot Sandhu. "Barriers to implementation of long-acting reversible contraception: A systematic review." Journal of the American Association of Nurse Practitioners 30.4 (2018): 236-243.
• Strasser, Julia, et al. "Bridging the Divide White Paper: Long-Acting Reversible Contraception (LARC) in the United States." (2016).
Women in the military have a high rate of unintended pregnancies, which is an issue both personally and with respect to the warfighting mission. One strategy to help servicewomen achieve ..... see more
The intrauterine contraceptive device (IUCD) is an effective and safe long-acting reversible contraceptive method., It is an important procedural competency skill for primary care physicians. - Procedural skill training has ..... see more
doi: 10.1111/1471-0528.16754. Online ahead of print. 1 Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden. 2 Department of Obstetrics and Gynaecology, Karolinska University Hospital, Stockholm, Sweden. 3 Department ..... see more
Introduction In the USA, approximately 45% of pregnancies are unintended. Accessing quality contraceptives can be a barrier for some individuals, especially low-income, uninsured, minority or younger women. These problems are ..... see more
From 1995 to 2014, intrauterine devices (IUDs) rose from ranking 10th (out of 11) among contraceptive methods to being the fourth most popular, outnumbered only by the pill, sterilization, and ..... see more
Abstract Abstract The Contraceptive Counselling (COCO) study tested whether a structured approach to assessing patient needs and expectations improved method choice and satisfaction with the contraceptive decision-making process. Physicians and ..... see more